Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036.
Saved in:
| Title: | Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036. |
|---|---|
| Authors: | Bonn-Miller MO; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.; Zynerba Pharmaceuticals, Inc., Devon, Pennsylvania., Banks SL; Zynerba Pharmaceuticals, Inc., Devon, Pennsylvania., Sebree T; Zynerba Pharmaceuticals, Inc., Devon, Pennsylvania. |
| Source: | Cannabis and cannabinoid research [Cannabis Cannabinoid Res] 2017 Jan 01; Vol. 2 (1), pp. 5-7. Date of Electronic Publication: 2017 Jan 01 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101684827 Publication Model: eCollection Cited Medium: Print ISSN: 2578-5125 (Print) Linking ISSN: 23788763 NLM ISO Abbreviation: Cannabis Cannabinoid Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2578-5125 |
|---|---|
| DOI: | 10.1089/can.2016.0038 |
